ResMed (RMD) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.95 -0.5%
EPS Growth %: +5.5%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +5.5%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.43, $0.11 better than the analyst estimate of $2.32. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts NTG Nordic Transport Group A/S (NTG:DC) at Overweight
- Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
- RBC Capital Starts StepStone Group (STEP) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
